Pure Global AI
NCT06337734Completed

An Artificial Intelligence-Assisted Digital Health Lifestyle Intervention for Adults With Hypertension

The Effect of an Artificial Intelligence-based, Autonomous, Digital Health Intervention Using Precise Lifestyle Guidance on Blood Pressure in Adults With Hypertension: Single-Arm Nonrandomized Trial
University of California, San DiegoClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Hypertension
Drug/Device/Intervention
AI-Driven Lifestyle Coaching Program
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of California, San Diego
Location
La Jolla, United States of America
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2021
End date
Aug 01, 2023
Enrollment
141 participants
Primary outcome

Average change in systolic blood pressure (SBP) from baseline to 12 weeks,Average change in diastolic blood pressure (DBP) from baseline to 12 weeks,Average change in SBP from baseline to 24 weeks,Average change in DBP from baseline to 24 weeks,Percent change of participants with controlled BP (SBP130 and DBP80) from baseline to 12 weeks,Percent change of participants with controlled BP (SBP130 and DBP80) from baseline to 24 weeks,Percent change of participants with Stage 2 Hypertension (SBP≥140 or DBP≥90) from baseline to 12 weeks,Percent change of participants with Stage 2 Hypertension (SBP≥140 or DBP≥90) from baseline to 24 weeks

Summary

This study evaluates the impact of a fully digital, autonomous, and artificial intelligence
 (AI)-driven lifestyle coaching program on managing blood pressure (BP) among adults diagnosed
 with hypertension. Participants received a BP monitor and a wearable activity tracker to
 facilitate data collection. This data, along with responses from a questionnaire mobile app,
 were analyzed by an automated analytics engine employing statistical and machine learning
 techniques. The program delivered tailored lifestyle coaching directly to participants
 through a mobile app, aiming for precise and effective BP management.

ICD-10 classifications
Hypertensive diseasesRenovascular hypertensionSecondary hypertensionOther secondary hypertensionHypertensive heart disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06337734
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06337734 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, San Diego and is currently Completed. The study focuses on Hypertension. Target enrollment is 141 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.